BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 15219500)

  • 1. Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction.
    Claeys MJ; Bosmans J; De Ceuninck M; Beunis A; Vergauwen W; Vorlat A; Vrints CJ
    Am J Cardiol; 2004 Jul; 94(1):9-13. PubMed ID: 15219500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Grygier M; Araszkiewicz A; Lesiak M; Janus M; Kowal J; Skorupski W; Pyda M; Mitkowski P; Grajek S
    Am J Cardiol; 2011 Apr; 107(8):1131-5. PubMed ID: 21310372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
    Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
    Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial.
    Fokkema ML; Vlaar PJ; Vogelzang M; Gu YL; Kampinga MA; de Smet BJ; Jessurun GA; Anthonio RL; van den Heuvel AF; Tan ES; Zijlstra F
    Circ Cardiovasc Interv; 2009 Aug; 2(4):323-9. PubMed ID: 20031735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
    Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of new method of intracoronary adenosine injection during primary percutaneous coronary intervention on microvascular reperfusion injury - clinical outcome and 1-year follow-up.
    Grygier M; Araszkiewicz A; Lesiak M; Grajek S
    Cardiology; 2013; 124(3):199-206. PubMed ID: 23548697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: a randomized controlled clinical trial.
    Garcia-Dorado D; García-del-Blanco B; Otaegui I; Rodríguez-Palomares J; Pineda V; Gimeno F; Ruiz-Salmerón R; Elizaga J; Evangelista A; Fernandez-Avilés F; San-Román A; Ferreira-González I
    Int J Cardiol; 2014 Dec; 177(3):935-41. PubMed ID: 25449504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction.
    Desmet W; Bogaert J; Dubois C; Sinnaeve P; Adriaenssens T; Pappas C; Ganame J; Dymarkowski S; Janssens S; Belmans A; Van de Werf F
    Eur Heart J; 2011 Apr; 32(7):867-77. PubMed ID: 21196444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
    Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
    Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial.
    Nazir SA; Khan JN; Mahmoud IZ; Greenwood JP; Blackman DJ; Kunadian V; Been M; Abrams KR; Wilcox R; Adgey AA; McCann GP; Gershlick AH
    Trials; 2014 Sep; 15():371. PubMed ID: 25252600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Level of Selvester QRS score is predictive of ST-segment resolution and 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention.
    Uyarel H; Cam N; Okmen E; Kasikcioglu H; Tartan Z; Akgul O; Simsek D; Cetin M; Bozbeyoglu E; Buturak A; Uzunlar B
    Am Heart J; 2006 Jun; 151(6):1239.e1-7. PubMed ID: 16781226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome.
    Claeys MJ; Bosmans J; Veenstra L; Jorens P; De RaedtH ; Vrints CJ
    Circulation; 1999 Apr; 99(15):1972-7. PubMed ID: 10209000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
    Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
    JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent.
    Quintana M; Kahan T; Hjemdahl P
    Am J Cardiovasc Drugs; 2004; 4(3):159-67. PubMed ID: 15134468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperoxemic perfusion of the left anterior descending coronary artery after primary angioplasty in anterior ST-elevation myocardial infarction.
    Trabattoni D; Bartorelli AL; Fabbiocchi F; Montorsi P; Ravagnani P; Pepi M; Celeste F; Maltagliati A; Marenzi G; O'Neill WW
    Catheter Cardiovasc Interv; 2006 Jun; 67(6):859-65. PubMed ID: 16649231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous administration of adenosine triphosphate disodium during primary percutaneous coronary intervention attenuates the transient rapid improvement of myocardial wall motion, not myocardial stunning, shortly after recanalization in acute anterior myocardial infarction.
    Tokuyama T; Sakuma T; Motoda C; Kawase T; Takeda R; Mito S; Tamekiyo H; Otsuka M; Okimoto T; Toyofuku M; Hirao H; Muraoka Y; Ueda H; Masaoka Y; Hayashi Y
    J Cardiol; 2009 Oct; 54(2):289-96. PubMed ID: 19782267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial.
    Eitel I; Wöhrle J; Suenkel H; Meissner J; Kerber S; Lauer B; Pauschinger M; Birkemeyer R; Axthelm C; Zimmermann R; Neuhaus P; Brosteanu O; de Waha S; Desch S; Gutberlet M; Schuler G; Thiele H
    J Am Coll Cardiol; 2013 Apr; 61(13):1447-54. PubMed ID: 23466078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary ST segment evolution during primary coronary stenting predicts infarct zone recovery.
    Balian V; Galli M; Repetto S; Luvini M; Galdangelo F; Castiglioni B; Boscarini M; Petrucci E; Filippini G; Marcassa C
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):53-60. PubMed ID: 15619303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.